Clare Louise Fraser

Clare Louise Fraser

Auto-generated profile, based on publicly available information

Clare Louise Fraser

Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
DMDan Milea
Dan Milea
Raymond P. NajjarRaymond P. Najjar
Raymond P. Najjar
ZJZhubo Jiang
Zhubo Jiang
DTDaniel Ting
Daniel Ting
CVCaroline Vasseneix
Caroline Vasseneix
VBValérie Biousse
Valérie Biousse
Nonophthalmologist physicians do not confidently perform direct ophthalmoscopy. The use of artificial intelligence to detect papilledema and other optic-disk abnormalities from fundus photographs has not been well studied.

1 May 2016 in The Lancet Neurology
Verified
Journal Article
Closed access
EMElena H Martinez-Lapiscina
Elena H Martinez-Lapiscina
SASam Arnow
Sam Arnow
JWJames A Wilson
James A Wilson
SSShiv Saidha
Shiv Saidha
JPJana Lizrova Preiningerova
Jana Lizrova Preiningerova
PVPablo Villoslada
Pablo Villoslada

8 July 2014 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
APaxel petzold
axel petzold
MWMike P. Wattjes
Mike P. Wattjes
FCFiona Costello
Fiona Costello
JFJose Flores-Rivera
Jose Flores-Rivera
CFClare L. Fraser
Clare L. Fraser
GPGordon T. Plant
Gordon T. Plant

1 September 2018 in Journal of Neuro-Ophthalmology
Verified
Journal Article
Closed access
LMLasse Malmqvist
Lasse Malmqvist
LBLulu Msc Bursztyn
Lulu Msc Bursztyn
FCFiona Costello
Fiona Costello
KDKathleen Digre
Kathleen Digre
JFJ. Alexander Fraser
J. Alexander Fraser
Steffen HamannSteffen Hamann
Steffen Hamann
Background: Making an accurate diagnosis of optic disc drusen (ODD) is important as part of the work-up for possible life-threatening optic disc edema. It also is important to follow the slowly progressive visual field defects many patients with ODD experience. The introduction of enhanced depth imaging optical coherence tomography (EDI-OCT) has improved the visualization of more deeply buried ODD. There is, however, no consensus regarding the diagnosis of ODD using OCT. The purpose of this study was to develop a consensus recommendation for diagnosing ODD using OCT. Methods: The members of the Optic Disc Drusen Studies (ODDS) Consortium are either fellowship trained neuro-ophthalmologists with an interest in ODD, or researchers with an interest in ODD. Four standardization steps were performed by the consortium members with a focus on both image acquisition and diagnosis of ODD. Results: Based on prior knowledge and experiences from the standardization steps, the ODDS Consortium reached a consensus regarding OCT acquisition and diagnosis of ODD. The recommendations from the ODDS Consortium include scanning protocol, data selection, data analysis, and nomenclature. Conclusions: The ODDS Consortium recommendations are important in the process of establishing a reliable and consistent diagnosis of ODD using OCT for both clinicians and researchers.

1 August 2011 in Stroke
Verified
Journal Article
Closed access
CCCelia S. Chen
Celia S. Chen
ALAndrew W. Lee
Andrew W. Lee
BCBruce Campbell
Bruce Campbell
TLTien Lee
Tien Lee
MPMark Paine
Mark Paine
RMRomesh Markus
Romesh Markus
Background and Purpose—: Central retinal artery occlusion is caused by a platelet-fibrin thrombus or embolic occlusion and is a stroke of the eye. Observational studies suggest that thrombolytics may restore ocular perfusion and visual function. We hypothesized that intravenous tissue-type plasminogen activator (tPA) administered within 24 hours of symptom onset might restore ocular perfusion and visual function. Methods—: A placebo-controlled, randomized trial of intravenous tPA versus intravenous saline was performed in patients with clinically defined central retinal artery occlusion within 24 hours of symptom onset. tPA was administered at a total dose of 0.9 mg/kg, with 10% given as a 1-minute bolus and the remainder over 1 hour. An improvement of visual acuity of 3 lines or more was considered significant. Results—: Twenty-five percent (2 of 8) of the tPA group experienced the primary outcome at 1 week after tPA versus none of the placebo group. One patient had an intracranial hemorrhage. The visual acuity improvement of these 2 patients was not sustained at 6 months. In both patients, tPA was administered within 6 hours of symptom onset. Conclusions—: Although essentially a negative study, it does add to the evidence base of reperfusion in central retinal artery occlusion by showing that the time window for intervention is likely to be <6 hours. Reocclusion is a potential problem and may require adjuvant anticoagulation. Future studies should concentrate on determining the efficacy of thrombolytics in the <6-hour time window. Clinical Trial Registration—: URL: http://www.anzctr.org.au . Unique identifier: 83102.

8 March 2019 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
ASAnthony M. Sammel
Anthony M. Sammel
EHEdward Hsiao
Edward Hsiao
GSGeoffrey Schembri
Geoffrey Schembri
KNKatherine Nguyen
Katherine Nguyen
JBJanice Brewer
Janice Brewer
RLRodger Laurent
Rodger Laurent